|
| |
Image Results
Loading...
Loading...
Pdli July 2007 Pages on BioPortfolio:
BioPortfolio - PDL BioPharma - Profile
We have developed a mammalian cell surface display vector, suitable for...25th July, 2007. PDL BioPharma, Fremont, CA, USA.- Lab Anim (NY). 2007 May ...
http://www.bioportfolio.com/biocorporate/27960-PDL%2BBioPhar...
|
BioPortfolio - PDL - Profile
The main routes of oxygen ingress into wine bottles through "technical"...25th July, 2007. PDL BioPharma, Fremont, CA, USA.- Lab Anim (NY). 2007 May ...
http://www.bioportfolio.com/biocorporate/8122-PDL.pdf...
|
BioPortfolio - Array BioPharma - Profile
Cholesteryl ester transfer protein is a plasma glycoprotein that transfers... 25th July, 2007. Array BioPharma, 3200 Walnut Street Boulder, CO 80301, USA. ...
http://www.bioportfolio.com/biocorporate/959-Array%2BBioPhar...
|
|
BioPortfolio - AMBRILIA BIOPHARMA - Profile
2007 Nov;51(11):4036-43. Epub 2007 Jul 16. (DOI Direct Link) ... 30th July, 2009 . PDL BioPharma, Inc. -- The failure of licensees to ...
http://www.bioportfolio.com/biocorporate/35395-AMBRILIA%252B...
|
BioPortfolio - Enzon Incorporated - Profile
... to overcome the problems of enzymatic degradation and short...11th July, 2007 ... PDLI) today announced that it closed on its previously disclosed $300
...
http://www.bioportfolio.com/biocorporate/3851-Enzon%2BIncorp...
|
BioPortfolio - Biolog Incorporated - Profile
... subinhibitory concentrations of amikacin and ciprofloxacin...27th July, 2007 ... PDLI) today announced that it closed on its previously disclosed $300 ...
http://www.bioportfolio.com/biocorporate/1612-Biolog%2BIncor...
|
BioPortfolio - GVK Biosciences Private Limited - Profile
Glycogen Synthase Kinase 3beta is one of the important targets in the...24th July, 2007 ... PDLI) today announced that it closed on its previously ...
http://www.bioportfolio.com/biocorporate/23767-GVK+Bioscienc...
|
BioPortfolio - ChemDiv Incorporated - Profile
We have developed a series of novel potent...7th September, 2007 ... Novel derivatives of 1,2,4-triazoles are described as potent...18th July, 2007 ...
PDLI) today announced that it closed on its previously disclosed ...
http://www.bioportfolio.com/biocorporate/2660-ChemDiv%2BInco...
|
BioPortfolio - Synarc Incorporated - Profile
The aim of our study was to investigate the sex- and age-related changes...3rd July, 2009 ... the management of osteoporosis in adults: the 2007 ISCD Official
... PDLI) today announced that it closed on its previously disclosed ...
http://www.bioportfolio.com/biocorporate/9915-Synarc%252BInc...
|
BioPortfolio - Cedarburg Pharmaceuticals Incorporated - Profile
Inhaled nitric oxide (iNO) has altered the management strategy for...21st July, 2007 ... PDLI) today announced that it closed on its previously ...
http://www.bioportfolio.com/biocorporate/34622-Cedarburg+Pha...
| Results from other life science and pharmaceutical sites:
PDL BioPharma : About Us : Board of Directors : Joseph Klein III
Joseph Klein III was elected a director of the Company in July 2007. Mr. Klein currently serves as Managing Director of Gauss Capital Advisors, LLC, ...
http://www.pdl.com/index.cfm?navId=184...
|
Summary of PDL BIOPHARMA, INC. - Yahoo! Finance
On April 10, 2008, PDL BioPharma, Inc. ("PDL" or "we") announced our intention to spin .... Synagis will generally expire in March 2013, July 2014 and August
2014, respectively. ... In 2007 and the nine months ended September 30, 2008,
...
http://biz.yahoo.com/e/081223/pdli8-k.html...
|
UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE CHILDREN'S HOSPITAL ...
America, Inc. (LFA), for her work entitled Colony PDLI as a Marker of ... Family Centered Care, July 30-August 1, 2007, Seattle, WA, sponsored by the ...
http://www.washington.edu/medicine/pediatrics/docs/newslette...
|
Summary of PDL BIOPHARMA, INC. - Yahoo! Finance
In 2007, we and Biogen Idec announced that the CHOICE trial, a phase 2, ... In July 2008, we initiated a phase 1 combination trial of elotuzumab with ...
http://biz.yahoo.com/e/081107/pdli10-q.html...
|
Isis Pharmaceuticals | Board of Directors
... Inc. since June 2005; OSI Pharmaceuticals, Inc. since July 2006; PDL BioPharma, Inc. since July 2007; and Savient Pharmaceuticals, Inc. since May
2006. ...
http://www.isispharm.com/About-Isis/Management-and-Board/Boa...
|
Article : GEN's Annual Wall Street Analyst Roundup Genetic ...
1 Feb 2008 ... ImClone (IMCL), Sepracor (SEPR), and PDL BioPharma (PDLI) all hired bankers .... RR: Beginning with the July 2007 “American Association of ...
http://www.genengnews.com/articles/chitem.aspx?aid=2355&chid...
|
2008 Newsletter | Mike Cox Lab | Biochemistry | UW-Madison
28 Jul 2008 ... He received his PhD in July 2007. He is joined in Madison by his wife, ... Sarita Jain is now at PDL BioPharma, Inc in Fremont, California. ...
http://www.biochem.wisc.edu/newsletters/2008/cox_lab.aspx...
|
35 Mike Cox Lab Mo Cleland Lab
Lanzov in July 2007. Julia Cox defended her thesis February 2007 ... Sarita Jain is now at PDL BioPharma, Inc in. Fremont, California. ...
https://www.biochem.wisc.edu/newsletters/2008/pdfs/biochem_n...
|
Roche - Investor Updates
Investor Updates 2007 ... 01. November 2005. Roche and Protein Design Labs to jointly develop daclizumab in transplant maintenance therapy ... 19. July 2005.
Reminder: 20 July - Roche´s 2005 Half Year Results and Report ...
http://www.roche.com/investors/ir_update.htm?tab=4...
|
January 7, 2008
an MAA for the same indication in July 2007. Schering-Plough acquired .... plant rejection under a license from PDL BioPharma Inc. (NASDAQ:PDLI, ...
http://www.biocentury.com/bcapp/BioCenturyCommon/CustomerSer...
|
|
